{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:00:06Z","timestamp":1790229606717,"version":"4.1.0"},"reference-count":52,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2014,9,26]],"date-time":"2014-09-26T00:00:00Z","timestamp":1411689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Obstet and Gynaecol"],"published-print":{"date-parts":[[2015,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>To compare the corticosteroidogenic enzyme activities between normal cycling non\u2010polycystic ovary syndrome (<jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>), and normoandrogenic <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">NA<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>) and hyperandrogenic <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">HA\u2010PCOS<\/jats:styled-content>) patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This cohort study was conducted at <jats:styled-content style=\"fixed-case\">J<\/jats:styled-content>ulio <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>uller <jats:styled-content style=\"fixed-case\">U<\/jats:styled-content>niversity <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>ospital and <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>ropical <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>nstitute of <jats:styled-content style=\"fixed-case\">R<\/jats:styled-content>eproductive <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>edicine and <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>enopause, and enrolled 114 non\u2010<jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content> women and 355 <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content> patients. The steroidogenic enzyme activities were measured using the serum steroid product\/precursor molar ratio.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the \u03945 pathway the 17,20 lyase activity was equally low in the <jats:styled-content style=\"fixed-case\">NA\u2010PCOS<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">HA\u2010PCOS<\/jats:styled-content> women compared with the non\u2010<jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content> women (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01 and <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001, respectively). In the \u03944 pathway, the 17,20 lyase activity was higher only in the <jats:styled-content style=\"fixed-case\">HA\u2010PCOS<\/jats:styled-content> group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The 17\u2010hydroxylase activity was the same in <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content> and non\u2010<jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content> subjects (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). The 3\u03b2\u2010hydroxysteroid dehydrogenase II (3\u03b2\u2010<jats:styled-content style=\"fixed-case\">HSDII<\/jats:styled-content>) activity was higher in the conversion of dehydroepiandrosterone into androstenedione in the <jats:styled-content style=\"fixed-case\">HA\u2010PCOS<\/jats:styled-content> than in the <jats:styled-content style=\"fixed-case\">NA\u2010PCOS<\/jats:styled-content> (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) and the non\u2010<jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content> patients (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). The aromatase activity was lower in the <jats:styled-content style=\"fixed-case\">HA\u2010PCOS<\/jats:styled-content> than in the <jats:styled-content style=\"fixed-case\">NA\u2010PCOS<\/jats:styled-content> (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) patients and non\u2010<jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content> subjects (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). In <jats:styled-content style=\"fixed-case\">HA\u2010PCOS<\/jats:styled-content> subjects, the 17,20 lyase activity was related to insulin, estradiol, total testosterone concentrations and free androgen index in the \u03945 pathway. 3\u03b2\u2010<jats:styled-content style=\"fixed-case\">HSDII<\/jats:styled-content> showed weak correlation with estradiol in the <jats:styled-content style=\"fixed-case\">HA\u2010PCOS<\/jats:styled-content> group. Anthropometric parameters had little impact, if any, on the steroidogenic enzyme activities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The <jats:styled-content style=\"fixed-case\">NA\u2010PCOS<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">HA\u2010PCOS<\/jats:styled-content> patients demonstrated different enzyme activities, and the results provided new directions for future studies including <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content> patients with different phenotypes.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jog.12524","type":"journal-article","created":{"date-parts":[[2014,9,26]],"date-time":"2014-09-26T05:35:01Z","timestamp":1411709701000},"page":"254-263","source":"Crossref","is-referenced-by-count":38,"title":["Comparison of steroidogenic pathways among normoandrogenic and hyperandrogenic polycystic ovary syndrome patients and normal cycling women"],"prefix":"10.1111","volume":"41","author":[{"given":"Sebasti\u00e3o Freitas","family":"de Medeiros","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology Medical Science School \u2013 UFMT  Cuiab\u00e1 Mato Grosso Brazil"},{"name":"Julio Muller University Hospital  Cuiab\u00e1 Mato Grosso Brazil"},{"name":"Tropical Institute of Reproductive Medicine and Menopause  Cuiab\u00e1 Mato Grosso Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacklyne Silva","family":"Barbosa","sequence":"additional","affiliation":[{"name":"Tropical Institute of Reproductive Medicine and Menopause  Cuiab\u00e1 Mato Grosso Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcia Marly Winck","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Julio Muller University Hospital  Cuiab\u00e1 Mato Grosso Brazil"},{"name":"Tropical Institute of Reproductive Medicine and Menopause  Cuiab\u00e1 Mato Grosso Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,9,26]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.2321049.x"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.07.008"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03346454"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/er.2003-0030"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-27302013000600005"},{"key":"e_1_2_7_7_1","first-page":"377","volume-title":"Polycystic Ovary Syndrome","author":"Zawadski JK","year":"1992"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0178"},{"key":"e_1_2_7_9_1","first-page":"541","article-title":"Adrenal androgen participation in the polycystic ovary syndrome","volume":"32","author":"Gil\u2010Junior AB","year":"2010","journal-title":"Rev Bras Gynecol Obstet"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032046"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)53510-9"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1370670"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.2.603"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1159\/000050360"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199207163270304"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.12.4075"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1382"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-57-2-320"},{"key":"e_1_2_7_20_1","volume-title":"Obesity: Preventing and Managing the Global Epidemic. Report of A World Health Organization Consultation","author":"WHO Consultion on Obesity","year":"2000"},{"key":"e_1_2_7_21_1","volume-title":"Research on Obesity. A Repot of the DHSS\/MRC Group","author":"James WPT","year":"1976"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(91)90059-I"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030617"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2243"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030350"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deg082"},{"key":"e_1_2_7_27_1","first-page":"587","article-title":"Zona fasciculata 21\u2010hydroxysteroids and precursor\u2010to\u2010product ratios in 21\u2010hydroxylase deficiency: Further characterization of classic and non\u2010classic patients and heterozygote carriers","volume":"34","author":"Costa\u2010Barbosa FA","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-26-1-46"},{"key":"e_1_2_7_29_1","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/mend.13.6.0311","article-title":"Aumented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries","volume":"13","author":"Nelson VL","year":"1999","journal-title":"Mol Endo"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2006.068445"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1123"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198903023200904"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1470473"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2053"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-2200"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2006.05.005"},{"key":"e_1_2_7_37_1","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/jcem.87.2.8240","article-title":"Genetics of serum dehydroepiandrosterone sulfate and its relationship to insulin in a population\u2010based cohort of twin subjects","volume":"87","author":"Nestler JE","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.132.6.2498"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.6.3158"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.02755.x"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1159\/000066263"},{"key":"e_1_2_7_42_1","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1210\/endo.141.4.7402","article-title":"Effect of leptin on CYP17 enzymatic activies in human adrenal cells: New insights in the onset of adrenarche","volume":"141","author":"Biason\u2010Lauber A","year":"2000","journal-title":"Endocrinology"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.7.2343"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-60-3-428"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)48741-8"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.6.2611"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/0039-128X(83)90019-3"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199009273231302"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod46.1.73"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(87)90127-0"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0395"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.06.025"},{"key":"e_1_2_7_53_1","first-page":"400","article-title":"Adrenal androgen excess in women: Lack of a role for 17\u2010hydroxylase and 17, 20\u2010lyase dysregulation","volume":"80","author":"Azziz R","year":"1995","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Obstetrics and Gynaecology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjog.12524","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjog.12524","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jog.12524","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T19:06:05Z","timestamp":1696273565000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/jog.12524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,26]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.1111\/jog.12524"],"URL":"https:\/\/doi.org\/10.1111\/jog.12524","archive":["Portico"],"relation":{},"ISSN":["1341-8076","1447-0756"],"issn-type":[{"value":"1341-8076","type":"print"},{"value":"1447-0756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,26]]}}}